{"transactions":[{"id":4627550,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-09-28T20:08:12.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":9160,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to cancellation of a warrant granted on June 10, 2025, and was awarded a new warrant as part of his appointment to the board of directors of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants vest 25% on April 14, 2027 and thereafter in 36 equal monthly installments."}],"balance_after":9160,"derivative":{"exercise_price":249.84,"expiration_date":"2036-04-14","underlying":"Ordinary Shares","underlying_shares":9160},"source":{"system":"sec-edgar","filing":"0001610717-26-000423","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000423/form4.xml","form_type":"4"}},{"id":4627549,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-09-28T20:08:12.000Z","date":"2026-04-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9160,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to cancellation of a warrant granted on June 10, 2025, and was awarded a new warrant as part of his appointment to the board of directors of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants vest 25% on June 10, 2026 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":172.35,"expiration_date":"2035-06-10","underlying":"Ordinary Shares","underlying_shares":9160},"source":{"system":"sec-edgar","filing":"0001610717-26-000423","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000423/form4.xml","form_type":"4"}},{"id":4613542,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":58996,"kind":"person","name":"Bodenhoff Mads","position":1,"cik":"0002014697","reported_name":"Bodenhoff Mads","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & PAO"}}],"security":"Warrants","published_at":"2026-09-09T21:04:07.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants vested 25% on October 11, 2023 and thereafter in 36 equal monthly installments."}],"balance_after":687,"derivative":{"exercise_price":110,"expiration_date":"2032-10-11","underlying":"Ordinary Shares","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001610717-26-000409","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2014697/000161071726000409/form4.xml","form_type":"4"}},{"id":4613541,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":58996,"kind":"person","name":"Bodenhoff Mads","position":1,"cik":"0002014697","reported_name":"Bodenhoff Mads","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & PAO"}}],"security":"Ordinary Shares","published_at":"2026-09-09T21:04:07.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":270.19,"value":810570.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-26-000409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014697/000161071726000409/form4.xml","form_type":"4"}},{"id":4613540,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":58996,"kind":"person","name":"Bodenhoff Mads","position":1,"cik":"0002014697","reported_name":"Bodenhoff Mads","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & PAO"}}],"security":"Ordinary Shares","published_at":"2026-09-09T21:04:07.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":110,"value":330000.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001610717-26-000409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014697/000161071726000409/form4.xml","form_type":"4"}},{"id":2068,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":1629,"kind":"person","name":"HOLTUG LARS","position":1,"cik":"0001965626","reported_name":"HOLTUG LARS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-03T20:09:06.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":236,"price":264.1296,"value":62334.5856,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001610717-26-000395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1965626/000161071726000395/form4.xml","form_type":"4"}},{"id":683459,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-19T01:02:43.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":246.91,"value":222219.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $246.48 to $247.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2900,"source":{"system":"sec-edgar","filing":"0001610717-26-000360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000360/form4.xml","form_type":"4"}},{"id":683458,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-19T01:02:43.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":245.85,"value":270435.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $245.41 to $246.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001610717-26-000360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000360/form4.xml","form_type":"4"}},{"id":754726,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":42385,"kind":"person","name":"SMITH SCOTT THOMAS","position":1,"cik":"0001965550","reported_name":"SMITH SCOTT THOMAS","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-02T20:25:15.000Z","date":"2026-06-02","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":219,"value":21900.0,"ownership":{"direct":true},"balance_after":4367,"source":{"system":"sec-edgar","filing":"0001610717-26-000179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000179/form4.xml","form_type":"4"}},{"id":757029,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:11:13.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":223.5,"value":22350.0,"ownership":{"direct":true},"balance_after":900,"source":{"system":"sec-edgar","filing":"0001610717-26-000177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/form4.xml","form_type":"4"}},{"id":757028,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:11:13.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":222.3,"value":44460.0,"ownership":{"direct":true},"balance_after":800,"source":{"system":"sec-edgar","filing":"0001610717-26-000177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/form4.xml","form_type":"4"}},{"id":757027,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:11:13.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":223.76,"value":44752.0,"ownership":{"direct":true},"balance_after":600,"source":{"system":"sec-edgar","filing":"0001610717-26-000177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/form4.xml","form_type":"4"}},{"id":757030,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":42385,"kind":"person","name":"SMITH SCOTT THOMAS","position":1,"cik":"0001965550","reported_name":"SMITH SCOTT THOMAS","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:10:28.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":223.32,"value":55830.0,"ownership":{"direct":true},"balance_after":4267,"source":{"system":"sec-edgar","filing":"0001610717-26-000176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000176/form4.xml","form_type":"4"}},{"id":761735,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-27T20:05:26.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":239.3675,"value":47873.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $239.245 to $239.490 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001610717-26-000161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000161/form4.xml","form_type":"4"}},{"id":761734,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-27T20:05:26.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":236.235,"value":47247.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $235.93 to $236.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001610717-26-000161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000161/form4.xml","form_type":"4"}},{"id":782332,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":47969,"kind":"person","name":"JENSEN FLEMMING STEEN","position":1,"cik":"0001965612","reported_name":"JENSEN FLEMMING STEEN","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2026-05-12T20:08:41.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":19460,"price":238.4903,"value":4641021.238,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-26-000159","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000159/form4.xml","form_type":"4"}}]}